Logo image of ZENA

ZENATECH INC (ZENA) Stock Fundamental Analysis

NASDAQ:ZENA - CA98936T2083 - Common Stock

5.1 USD
+0.1 (+2%)
Last: 8/25/2025, 8:00:02 PM
5.0645 USD
-0.04 (-0.7%)
After Hours: 8/25/2025, 8:00:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ZENA. ZENA was compared to 282 industry peers in the Software industry. Both the profitability and financial health of ZENA have multiple concerns. ZENA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ZENA had negative earnings in the past year.
ZENA had a negative operating cash flow in the past year.
ZENA Yearly Net Income VS EBIT VS OCF VS FCFZENA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

ZENA has a worse Return On Assets (-23.55%) than 72.34% of its industry peers.
ZENA's Return On Equity of -48.27% is on the low side compared to the rest of the industry. ZENA is outperformed by 69.15% of its industry peers.
Industry RankSector Rank
ROA -23.55%
ROE -48.27%
ROIC N/A
ROA(3y)-4.77%
ROA(5y)N/A
ROE(3y)-7.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZENA Yearly ROA, ROE, ROICZENA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ZENA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZENA Yearly Profit, Operating, Gross MarginsZENA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

3

2. Health

2.1 Basic Checks

ZENA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZENA has been increased compared to 1 year ago.
Compared to 1 year ago, ZENA has an improved debt to assets ratio.
ZENA Yearly Shares OutstandingZENA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M 25M
ZENA Yearly Total Debt VS Total AssetsZENA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 6.18 indicates that ZENA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.18, ZENA is in the better half of the industry, outperforming 75.53% of the companies in the same industry.
A Debt/Equity ratio of 0.84 indicates that ZENA is somewhat dependend on debt financing.
The Debt to Equity ratio of ZENA (0.84) is worse than 71.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Altman-Z 6.18
ROIC/WACCN/A
WACC10.43%
ZENA Yearly LT Debt VS Equity VS FCFZENA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

ZENA has a Current Ratio of 1.34. This is a normal value and indicates that ZENA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.34, ZENA is in line with its industry, outperforming 43.62% of the companies in the same industry.
ZENA has a Quick Ratio of 1.34. This is a normal value and indicates that ZENA is financially healthy and should not expect problems in meeting its short term obligations.
ZENA has a Quick ratio (1.34) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34
ZENA Yearly Current Assets VS Current LiabilitesZENA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

ZENA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1637.14%.
ZENA shows a small growth in Revenue. In the last year, the Revenue has grown by 7.44%.
Measured over the past years, ZENA shows a decrease in Revenue. The Revenue has been decreasing by -4.94% on average per year.
EPS 1Y (TTM)-1637.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2482.86%
Revenue 1Y (TTM)7.44%
Revenue growth 3Y-4.94%
Revenue growth 5YN/A
Sales Q2Q%92.04%

3.2 Future

The Earnings Per Share is expected to decrease by -42.91% on average over the next years. This is quite bad
ZENA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 257.67% yearly.
EPS Next Y88.33%
EPS Next 2Y-42.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year492.66%
Revenue Next 2Y257.67%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZENA Yearly Revenue VS EstimatesZENA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 5M 10M 15M
ZENA Yearly EPS VS EstimatesZENA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZENA. In the last year negative earnings were reported.
Also next year ZENA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZENA Price Earnings VS Forward Price EarningsZENA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZENA Per share dataZENA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

A cheap valuation may be justified as ZENA's earnings are expected to decrease with -42.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.91%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ZENA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZENATECH INC

NASDAQ:ZENA (8/25/2025, 8:00:02 PM)

After market: 5.0645 -0.04 (-0.7%)

5.1

+0.1 (+2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-12 2025-08-12
Earnings (Next)11-12 2025-11-12
Inst Owners0.64%
Inst Owner Change167.48%
Ins Owners22.67%
Ins Owner ChangeN/A
Market Cap168.20M
Analysts82.86
Price Target9.18 (80%)
Short Float %15.87%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 93.31
P/FCF N/A
P/OCF N/A
P/B 12.59
P/tB 31.2
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.26
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.05
BVpS0.41
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.55%
ROE -48.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.77%
ROA(5y)N/A
ROE(3y)-7.88%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 585.26%
Cap/Sales 78.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z 6.18
F-Score1
WACC10.43%
ROIC/WACCN/A
Cap/Depr(3y)356.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)44.44%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1637.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2482.86%
EPS Next Y88.33%
EPS Next 2Y-42.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.44%
Revenue growth 3Y-4.94%
Revenue growth 5YN/A
Sales Q2Q%92.04%
Revenue Next Year492.66%
Revenue Next 2Y257.67%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1375.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-465%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-337.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-398.17%
OCF growth 3YN/A
OCF growth 5YN/A